发明名称 METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT
摘要 medicine. SUBSTANCE: method involves determining gamma-interferon level in patient blood serum and lacrimal fluid of the ill eye. Its contents being found to be equal to or greater than 200 pcg in blood serum or below 7000 pcg in the lacrimal fluid, worsening of clinical picture of the disease is to be predicted. EFFECT: enhanced accuracy of prognosis; evaluated metastasis risk. 1 tbl
申请公布号 RU2157998(C1) 申请公布日期 2000.10.20
申请号 RU19990117267 申请日期 1999.08.09
申请人 MOSKOVSKIJ NII GLAZNYKH BOLEZNEJ IMENI GEL'MGOL'TS 发明人 LIKHVANTSEVA V.G.;BROVKINA A.F.;SLEPOVA O.S.
分类号 G01N33/52;G01N33/53;(IPC1-7):G01N33/52 主分类号 G01N33/52
代理机构 代理人
主权项
地址